Tingley Whittemore: insider trades.
Tingley Whittemore reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($5K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Tingley Whittemore
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | Officer · Chief Medical Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Tenaya Therapeutics, Inc. | A | 49,000 | $0 | 263,073 | Form 4 |
| 2026-08-17 | Tenaya Therapeutics, Inc. | S | 1,637 | $0.71 | 219,860 | Form 4 |
| 2026-08-17 | Tenaya Therapeutics, Inc. | S | 1,871 | $0.71 | 216,352 | Form 4 |
| 2026-08-17 | Tenaya Therapeutics, Inc. | S | 2,279 | $0.71 | 214,073 | Form 4 |
| 2026-08-17 | Tenaya Therapeutics, Inc. | S | 1,637 | $0.71 | 218,223 | Form 4 |
Questions
What stock did Tingley Whittemore buy or sell?
Tingley Whittemore reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($5K), across 1 company.
Is Tingley Whittemore the same person as other filers with this name?
This page covers SEC CIK 1868494 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/tingley-whittemore-1868494.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.